MedPath

Salmeterol Effect on Exercise Performance

Not Applicable
Recruiting
Conditions
Healthy
Interventions
Drug: Placebo
Registration Number
NCT06655012
Lead Sponsor
University of Copenhagen
Brief Summary

The purpose of the project is to investigate the muscle anabolic response to acute beta2-adrenergic stimulation in young healthy men and women.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Inclusion Criteria:
  • Age 18-40
  • Physically active >5 hours a week
  • Maximum oxygen uptake classified as high or very high
Exclusion Criteria
  • Active smoker currently or within the past 5 years
  • Regular intake of medication deemed by the responsible study physician to affect the test parameters (hormonal contraception is accepted for women)
  • Chronic or acute illness deemed by the responsible study physician to affect the test parameters
  • Deviation from the study protocol
  • Lean mass index >21 kg/m²
  • Pregnancy
  • Smoker
  • Blood donation during the past 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
SalmeterolSalmeterolParticipants are administered salmeterol from an inhaler device
PlaceboPlaceboParticipants are administered placebo from an inhaler device
Primary Outcome Measures
NameTimeMethod
Power output during sprint testingThrough study completion, an average on 2 weeks

Power output measured in Watts during a sprint on a bike ergometer

Secondary Outcome Measures
NameTimeMethod
Power output during time trialThrough study completion, an average on 2 weeks

Mean power output measured in Watts during a time trial on a bike ergometer

Trial Locations

Locations (1)

August Krogh Building

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath